Go to main content

​​​​

Collaborations

The Phase 1 Unit is engaged in extensive national, Nordic and international collaborations to improve access to early clinical trials, precision oncology and translational cancer research.

National collaborations

​​Danish National Molecular Tumor Board

The Danish National Molecular Tumor Board (DN-MTB) is a weekly, multidisciplinary forum for presenting, discussing, and giving advice on treatment for cancer patients being molecularly profiled. More than 1200 patients are profiled nationally per year and discussed at the DN-MTB. 

Oncologists, molecular biologists and bioinformaticians, pathologists, and clinical geneticists from eight oncologic centers across Denmark attend the DN-MTB.

Danish ​​National Haematology Tumor Board

A multidisciplinary forum with monthly meetings open for all Danish haematology centres. In this forum, haematologists, pathologists, molecular biologists, clinical geneticists, and bioinformaticians present and discuss haematological patients with molecular/genetic profiling of their disease, and share advice on their management.

​​Trial Nation

Trial Nation offers a single, national entry point for life science companies, patient organizations and clinical researchers wishing to sponsor, participate in, and conduct clinical trials in Denmark.

​​Danish oncology departments and referral network

​​​University of Copenhagen and translational research partners

Through close collaborations with leading academic and translational research partners, we advance precision medicine by translating scientific discoveries into early clinical applications.

Some of our academic collaborators:

 ​

​​​Nordic collaborations

​​Nordic Molecular Tumor Board

The Phase 1 Unit is an active partner in the Nordic Molecular Tumor Board, bringing together experts from Denmark, Sweden, Norway, Finland and Iceland. The collaboration supports discussion of complex molecular profiling, identification of treatment opportunities and referral of patients to relevant early phase clinical trials across the Nordic countries.

​European collaborations

The Phase 1 Unit contributes to several European initiatives aimed at strengthening precision oncology, cross-border collaboration and equitable access to personalised medicine.

Current projects include:

These collaborations facilitate exchange of expertise, harmonisation of clinical practices and improved access to innovative diagnostics and treatments for patients across Europe.​

Last updated:
Responsible editor
Klik for at scrolle op eller ned p� siden G� til toppen af siden